Brief: Neurometrix Says Quell Technology Selected For Use In Clinical Trial Of TENS For Fibromyalgia
16/04/2020 18:32
April 16 (Reuters) - NeuroMetrix Inc NURO.O :
* NEUROMETRIX INC - QUELL TECHNOLOGY SELECTED FOR USE IN
LARGE,
NIH-FUNDED CLINICAL TRIAL OF TENS FOR FIBROMYALGIA
Source text for Eikon: ID:nGNX2vhRwP
Further company coverage: NURO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuroMetrix
See all newsBrief: Neurometrix To Be Acquired By Electrocore
Brief: Neurometrix Reiterates Its Review Of Strategic Alternatives
Brief: NeuroMetrix Announces Steps Taken To Enhance Shareholder Value
Brief: Ephraim Fields Reports 9.3% Stake In Neurometrix, Inc. As Of Feb 23, 2024 - SEC Filing
Brief: RS Fund Reports 14.4% Stake In Neurometrix Inc As Of Feb 13